U.S. markets close in 1 hour 28 minutes
  • S&P 500

    4,199.06
    +76.59 (+1.86%)
     
  • Dow 30

    33,234.96
    +460.55 (+1.41%)
     
  • Nasdaq

    12,810.98
    +317.05 (+2.54%)
     
  • Russell 2000

    1,964.40
    +51.51 (+2.69%)
     
  • Crude Oil

    92.23
    +1.73 (+1.91%)
     
  • Gold

    1,808.30
    -4.00 (-0.22%)
     
  • Silver

    20.65
    +0.17 (+0.82%)
     
  • EUR/USD

    1.0308
    +0.0091 (+0.89%)
     
  • 10-Yr Bond

    2.7920
    -0.0050 (-0.18%)
     
  • GBP/USD

    1.2231
    +0.0155 (+1.28%)
     
  • USD/JPY

    132.9960
    -2.1200 (-1.57%)
     
  • BTC-USD

    23,788.56
    +749.38 (+3.25%)
     
  • CMC Crypto 200

    560.22
    +29.00 (+5.46%)
     
  • FTSE 100

    7,507.11
    +18.96 (+0.25%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Lab Notes: Verrica continues push for skin disorder drug, raising $25M; Windtree weighing options

·5 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

This week's Lab Notes has items on a Chester County company's ongoing pursuit of approval for its lead drug candidate, a Bucks County company exploring its options after generating positive study results for an experimental angina drug, two local life sciences companies naming new chief medical officers, and more.